Quick Takeaways
- Tadataka Yamada has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $11,775,157.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Tadataka Yamada
- Location
- Mansfield, MA
- Summary
- The estimated net worth of Tadataka Yamada is at least $11,775,157 dollars as of 28 Jul 2021. Tadataka Yamada is the Director of Icosavax, Inc. and owns shares of Icosavax, Inc. stock worth about $11.78M.
- Signature
- /s/ Thomas Russo, Attorney-in Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Tadataka Yamada and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Icosavax, Inc. ($11,775,157).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Tadataka Yamada
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ICVX | Icosavax, Inc. | Director | $11,775,157 | 28 Jul 2021 | ||
| LONA | Athira Pharma, Inc. | Director | 28 May 2021 | |||
| PASG | Passage BIO, Inc. | Director | 27 May 2021 | |||
| PHAT | Phathom Pharmaceuticals, Inc. | Director | 21 May 2021 |
Insider Transactions Reported by Tadataka Yamada:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.